INKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mink Therapeutics Inc (INKT) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are neutral to bearish, insiders are selling heavily, and there are no significant positive catalysts or recent news to support a strong upward price movement. Additionally, the company's financial performance shows improvement in net income and EPS, but revenue remains stagnant at zero, which does not inspire confidence for long-term growth.
The MACD histogram is negative and contracting, RSI is neutral at 51.424, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 9.323, with resistance at 9.968 and support at 8.677. Overall, the technical indicators suggest a neutral to bearish trend.
Improvement in net income (up 59.84% YoY) and EPS (up 41.30% YoY) in the latest quarter.
Insiders are selling heavily, with a 432.67% increase in selling over the last month. No recent news or significant trading trends. Revenue remains at zero with no YoY growth.
In Q3 2025, the company reported net income of -2,887,709 (up 59.84% YoY) and EPS of -0.65 (up 41.30% YoY). However, revenue remains at zero, showing no growth.
No analyst rating or price target changes available.
